- Home
- CNTA vs WULF Comparison
CNTA vs WULF Comparison
Compare CNTA & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | WULF |
|---|---|---|
| Founded | 2020 | 1952 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.8B |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | CNTA | WULF |
|---|---|---|
| Price | $39.68 | $23.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $43.17 | $20.86 |
| AVG Volume (30 Days) | 1.1M | ★ 23.6M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.13 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,000,000.00 | ★ $168,455,000.00 |
| Revenue This Year | N/A | $126.80 |
| Revenue Next Year | N/A | $162.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 20.28 |
| 52 Week Low | $11.55 | $3.70 |
| 52 Week High | $40.26 | $27.47 |
Technical Indicators
Market Signals| Indicator | CNTA | WULF |
|---|---|---|
| Relative Strength Index (RSI) | 62.46 | 48.74 |
| Support Level | $39.36 | $10.97 |
| Resistance Level | $39.86 | $25.75 |
| Average True Range (ATR) | 0.13 | 1.64 |
| MACD | -0.15 | -0.11 |
| Stochastic Oscillator | 25.93 | 45.84 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.